盐酸氨溴索联合丙酸倍氯米松雾化吸入治疗慢性阻塞性肺疾病临床观察

黎志峰

（陕西省宝鸡市陈仓医院，陕西 宝鸡，721300）

浏览次数：199次 下载次数：366次

摘要：

目的 探究盐酸氨溴索联合丙酸倍氯米松雾化吸入治疗慢性阻塞性肺疾病的临床疗效。方法 选取我院2013年1月至 2016年1月收治的130例慢性阻塞性肺疾病患者作为研究对象。随机分为对照组和观察组，每组65例患者。对照组采用盐 酸氨溴索作为治疗药物，观察组在对照组的用药基础上再加入丙酸倍氯米松雾化吸入治疗。治疗结束后对比两组患者的总 有效率以及不良反应（恶心、胃部灼热、消化不良）发生情况。结果 观察组患者的总有效率为95.38%，明显高于对照组的81.54%，差异具有统计学意义（P<0.05）；观察组患者的不良反应率为3.08%，明显低于对照组的15.38%，差异具有统计学意 义（P<0.05）。结论 盐酸氨溴索联合丙酸倍氯米松雾化吸入治疗慢性阻塞性肺疾病临床效果显著，可有效减少患者的不良反应发生率，值得在临床中推广及应用。

关键词：盐酸氨溴索；丙酸倍氯米松雾化吸入治疗；慢性阻塞性肺疾病

中图分类号：R563.9文献标志码：A文章编号：2096-1413(2016)26-0060-02

Clinical observation of ambroxol hydrochloride combined with beclomethasone dipropionate aerosol inhalation in the treatment of chronic obstructive pulmonary disease
LI Zhi-feng
(Chencang Hospital of Baoji City, Baoji 721300, China)

ABATRACT: Objective To explore the clinical effect of ambroxol hydrochloride combined with beclomethasone dipropionate aerosol inhalation in the treatment of chronic obstructive pulmonary disease. Methods One hundred and thirty patients with chronic obstructive pulmonary disease in our hospital from January 2013 to January 2016 were selected as study objects. The patients were randomly divided into control group and observation group, with 65 cases in each group. The control group was treated with ambroxol hydrochloride, while the observation group was treated with beclomethasone dipropionate aerosol inhalation on the basis of the control group. After the treatment, the total effective rate and adverse reactions (nausea, stomach burning, indigestion) between the two groups were compared. Results The total effective rate of the observation group was 95.38% , which was significantly higher than 81.54% of the control group, the difference was statistically significant (P<0.05). The adverse reaction rate of the observation group was 3.08% , which was significantly lower than 15.38% of the control group, the difference was statistically significant (P <0.05). Conclusion Ambroxol hydrochloride combined with beclomethasone dipropionate aerosol inhalation in the treatment of chronic obstructive pulmonary disease has a significant clinic effect, which can effectively reduce the adverse reaction rate, it is worthy promotion and application in clinic.

KEYWORDS: ambroxol hydrochloride; beclomethasone dipropionate aerosol inhalation treatment; chronic obstructive pulmonary disease

参考文献：
[1] 郭瑞.盐酸氨溴索对慢性阻塞性肺疾病急性加重期的效果观察[J]. 中国继续医学教育,2016,8(9):155-156.
[2] 刘红,万耘,钟宏菊.盐酸氨溴索辅助治疗老年慢性阻塞性肺疾病 的临床观察[J].中国药房,2016,27(15):2048-2050.
[3] 陈婉华,周伟成.盐酸氨溴索注射液用于慢性阻塞性肺疾病急性加 重期的疗效分析[J].现代诊断与治疗,2016,27(6):1072-1073.
[4] 白志桃.沙美特罗替卡松粉吸入剂与丙酸倍氯米松气雾剂治疗支 气管哮喘的效果观察[J].内蒙古医学杂志,2015,47(4):454-455.
[5] 王庆东.沙丁胺醇联合丙酸倍氯米松治疗成年人哮喘的疗效分析 [J].世界最新医学信息文摘:连续型电子期刊,2015,15(A1):143-144.